文献速递腹部技术与安全US

对比增强超声在多台扫描仪和分析软件包间量化团注通过参数的可重复性评估——定量影像生物标志物联盟研究

Evaluation of the Reproducibility of Bolus Transit Quantification With Contrast-Enhanced Ultrasound Across Multiple Scanners and Analysis Software Packages-A Quantitative Imaging Biomarker Alliance Study.
PubMed 文献 · Invest Radiol · 2020-01-01

该研究使用组织血流模体,评估4种商用超声扫描仪和3种分析软件包对肝脏病灶团注通过参数(上升时间、平均通过时间、峰值强度和曲线下面积)的可重复性。结果显示上升时间和平均通过时间在不同扫描仪和软件间变异较小,而峰值强度和曲线下面积的变异较大,目前幅度值无法直接跨系统比较。

要点

  • 上升时间是可重复性最好的团注通过参数,平均通过时间变异稍大。
  • 峰值强度和曲线下面积变异大,且因厂商线性化算法不同无法跨系统直接比较。
  • 时间参数(上升时间、平均通过时间)可在不同扫描仪和软件间进行比较。

核心结论

  • 使用本研究开发的协议和方法,可在不同扫描仪和分析软件上进行灌注量化并比较结果,为多中心患者评估奠定基础。

研究设计与样本

  • 研究使用组织血流模体,产生与临床肝脏病灶动态图像提取的时间-强度曲线非常相似。
  • 评估4种商用扫描仪(Philips iU22、Philips EPIQ、GE LOGIQ E9、Siemens Acuson Sequoia)和3种不同分析软件包,每种扫描仪进行15次试验。

诊断标准与关键数值

  • 单扫描仪单软件重复试验的变异系数:上升时间<8%,平均通过时间<12%,峰值强度<49%,曲线下面积<50%。
  • 不同扫描仪使用同一分析软件的变异:上升时间<9%,平均通过时间<21%。
  • 同一扫描仪使用不同分析软件的变异:上升时间<9%,平均通过时间<15%。

临床应用与阅片要点

  • 时间参数(上升时间、平均通过时间)可用于跨扫描仪和软件的比较,上升时间变异最小。
  • 目前由于厂商使用的任意线性化算法,幅度值(峰值强度、曲线下面积)不能在不同扫描仪和分析软件间直接比较。

局限性

  • 目前由于厂商使用的任意线性化算法,幅度值不能在不同扫描仪和分析软件间直接比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Contrast enhanced ultrasound (CEUS) is now broadly used clinically for liver lesion detection and characterization. Obstacles to the efforts to quantify perfusion with CEUS have been the lack of a standardized approach and undocumented reproducibility. The use of multiple scanners and different analysis software packages compounds the degree of variability. Our objectives were to standardize a CEUS-based approach for quantification of perfusion-related parameters of liver lesions and to evaluate the variability of bolus transit parameters (rise time [RT], mean transit time [MTT], peak intensity, and area under the curve) obtained from various clinical ultrasound scanners and analysis software.

MATERIALS AND METHODS: Bolus transit as a way of evaluating perfusion has been investigated both in vivo and in vitro in the past but without establishing its reproducibility. We developed a tissue flow phantom that produces time-intensity curves very similar to those extracted from clinical cine loops of liver lesions. We evaluated the variability of the bolus transit parameters with 4 commercial scanners (Philips iU22, Philips EPIQ, GE LOGIQ E9, and Siemens Acuson Sequoia) and 3 different analysis software packages in multiple trials (15 per scanner).

RESULTS: The variability (coefficient of variation) from repeated trials and while using a single scanner and software was less than 8% for RT, less than 12% for MTT, less than 49% for peak intensity, and less than 50% for area under the curve. Currently, it is not possible to directly compare amplitude values from different scanners and analysis software packages owing to the arbitrary linearization algorithm used among manufacturers; however, it is possible for time parameters (RT and MTT). The variability when using a different scanner with the same analysis software package was less than 9% for RT and less than 21% for MTT. The variability when using a different analysis software with the same scanner was less than 9% for RT and less than 15% for MTT. In all the evaluations we have performed, RT is the least variable parameter, while MTT is only slightly more variable.

CONCLUSIONS: The present study will lay the groundwork for multicenter patient evaluations with CEUS quantification of perfusion-related parameters with the bolus transit technique. When using the protocol and method developed here, it is possible to perform perfusion quantification on different scanners and analysis software and be able to compare the results. The current work is the first study that presents a comparison of bolus transit parameters derived from multiple systems and software packages.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Averkiou MA, Juang EK, Gallagher MK, et al. Evaluation of the Reproducibility of Bolus Transit Quantification With Contrast-Enhanced Ultrasound Across Multiple Scanners and Analysis Software Packages-A Quantitative Imaging Biomarker Alliance Study. Invest Radiol. 2020. PMID: 32898356. doi:10.1097/RLI.0000000000000702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。